Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,020 Results (Page 34 of 51)
- Relevance
  Sort by

Cold Pain Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

3-Kinase Delta Syndrome Market - Global Forecast 2025-2032

 Report
November 2025
183 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Anti-Ischemic Agents Market - Global Forecast 2026-2032

 Report
August 2026
182 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Non-Nucleoside Reverse Transcriptase Inhibitors Market - Global Forecast 2025-2030

 Report
August 2025
196 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Nucleoside Reverse Transcriptase Inhibitors Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Autologous Stem Cell & Non-Stem Cell Based Therapies Market - Global Forecast 2024-2030

 Report
March 2024
180 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Europe Cell & Gene Therapy Market - Focused Insights 2024-2029

 Report
June 2024
103 Pages
Europe

From

€1966EUR$2,200USD£1,682GBP

Industry Snapshots: US Biotechnology

 Newsletter
August 2026
50 Pages
United States

From

€214EUR$240USD£183GBP

Zinc Finger Nuclease Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4021EUR$4,500USD£3,440GBP

Investor Series: Opportunities in RNA Therapeutics Market

 Report
March 2023
174 Pages
Global

From

€1697EUR$1,899USD£1,452GBP

Pharmaceutical Contract Development and Manufacturing Organization (CMO) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

Metastatic Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2032

 Report
February 2022
308 Pages
Global

From

€8489EUR$9,500USD£7,263GBP

HIV Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Mode (Self-test), By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

 Report
January 2025
180 Pages
Global

From

€5317EUR$5,950USD£4,549GBP

Sexually Transmitted Disease (STD) Testing Market 2026-2030

 Report
January 2026
302 Pages
Global

From

€2234EUR$2,500USD£1,911GBP

Cell and Gene Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

Injectable Drugs Market - Global Forecast 2026-2032

 Report
August 2026
184 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

 Report
April 2022
326 Pages
Global

From

€3351EUR$3,750USD£2,867GBP

Cytomegalovirus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
June 2026
120 Pages
Global

From

€4245EUR$4,750USD£3,631GBP

Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029

 Report
July 2024
335 Pages
Global

From

€4423EUR$4,950USD£3,784GBP

Antibody Drug Conjugates Market 2026-2030

 Report
February 2026
288 Pages
Global

From

€2234EUR$2,500USD£1,911GBP

1,020 Results (Page 34 of 51)
- 1
- 32
- 33
- 34
- 35
- 36

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.